Company Overview

Development Stage

About the Company

[Summary] Anorectal health solution provider

Mayinglong Pharmaceutical Group Joint-stock Co., Ltd. (600993.SH), founded in 1582 AD, is a 'China Time-honored Brand' enterprise that has been operating continuously for over four hundred years. Adhering to the development philosophy of 'unified target customers, diversified service functions', the company is committed to providing professional, personalized, and diversified anorectal health solutions, vigorously developing the comprehensive health industry, and has formed a group enterprise integrating four major business segments: pharmaceutical industry, comprehensive health, medical services, and pharmaceutical commerce. Mayinglong inherits the essence of the 'Babao Famous Prescription' and has innovatively derived a variety of leading products such as Babao Eye Ointment, Mayinglong Shexiang Hemorrhoid Ointment, Shexiang Hemorrhoid Suppository, Longzhu Ointment, and Babao Eye Cream, forming a '1+2+X' product pattern with anorectal products as the core, ophthalmic and dermatological products as pillars, and multiple comprehensive health categories as extensions. Leveraging the brand influence in the anorectal field and the industrial structural advantages of its products, the company actively expands medical services and vigorously develops the comprehensive health industry. The company has been selected as one of 'China's 500 Most Valuable Brands' for 22 consecutive years. In 2025, its brand value reached 63.756 billion yuan. 'Mayinglong Eye Drops Manufacturing Technique' has been included in the national intangible cultural heritage, and the hemorrhoid plaster is rated as a 'Manufacturing单项 Champion Product' by the Ministry of Industry and Information Technology. Mayinglong Pharmaceutical Group Joint-stock Co., Ltd. is the only national-level vocational education teacher enterprise practice base in the 'Traditional Chinese Medicine' industry, carrying out vocational education based on industrial operation practice, promoting the mutual enhancement of teaching and learning, and work and study. It connects resources from government, industry, enterprises, and schools, implements vocational education and talent cultivation work for the entire pharmaceutical and medical industry chain, and strives to promote the innovative development of the traditional Chinese medicine industry and the construction of the talent team.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Mayinglong Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 主板
  • Deal: 上交所

Mayinglong How Fast Is Hiring Growing? (76 open positions)

Manage
Note: How fast is hiring at Mayinglong Pharmaceutical Group Joint-stock Co., Ltd. growing? Mayinglong2025: 150 openings (down 23%), 2024: 195 openings (down 6%), 2023: 207 openings (up 381%), 2022: 43 openings (down 90%), 2021: 437 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Mayinglong Master's Degree Job Demand Analysis

(More)
How fast is master's hiring at Mayinglong Pharmaceutical Group Joint-stock Co., Ltd. growing? MayinglongMaster's recruitment over the years: 2025: 10 openings (up 11%), 2024: 9 openings (down 63%), 2023: 24 openings (up 140%), 2022: 10 openings (down 44%), 2021: 18 openings.

Mayinglong Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
Mayinglong Doctoral Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Mayinglong Pharmaceutical Group Joint-stock Co., Ltd. growing? MayinglongDoctorate recruitment over the years: 2026: 6 openings (up 210%), 2024: 2 openings (down 63%), 2023: 5 openings (up 140%), 2022: 1 openings (down 44%).

Mayinglong R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Mayinglong Pharmaceutical Group Joint-stock Co., Ltd.? Based on an analysis of Mayinglong's job postings over the past year, "医疗卫生/美容保健类" demand: 9.7%, "计算机/网络/技术类": 7.3%, "美术/设计/创意类": 6.3%, "科研类": 4.9%, "其他(研发和技术类)": 3.4%, "生物/制药/化工/环保类": 2.9%. For reference only.

Mayinglong — What Are the Salaries Like? (206 records)

Manage
Mayinglong Salary Overview
salary range: 4.5K - 50K, 54.8% of roles pay ¥6-10K
Note: salary statistics are based on 206 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Mayinglong Pharmaceutical Group Joint-stock Co., Ltd.?Mayinglong54.8% of positions earn 6-10K, Undergraduate salary: ¥。销售类 average salary ¥9.7K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Mayinglong

(More)
Are salaries high at Mayinglong Pharmaceutical Group Joint-stock Co., Ltd.? We provide: 运营,销售,渠道,财务,跨境电商,零售,市场,信息,策划,生产经理,研究员,管培生,药店,产品开发,商务代表,推广,临床,主播,医疗器械,店员. Click to view detailed salary analysis by job.

Mayinglong Related Industry Tags

Job Category

  • 销售类
    20.3% of total 20.3%
  • 客户服务类
    15.1% of total 15.1%
  • 经营管理类
    15.1% of total 15.1%
  • 贸易/物流/采购/运输类
    11.3% of total 11.3%

Education

  • 本科
    58.5% of total 58.5%
  • 硕士
    19.3% of total 19.3%
  • 大专
    16.5% of total 16.5%
  • 博士
    2.8% of total 2.8%

Experience

  • 不限
    34% of total 34%
  • 3-5年
    27.8% of total 27.8%
  • 1-3年
    21.7% of total 21.7%
  • 5-10年
    16.5% of total 16.5%
View Detailed Analysis

What does Mayinglong Pharmaceutical Group Joint-stock Co., Ltd. require? Who is Mayinglong hiring? Mayinglong recruitment: 销售类占比最多占20.3%,其次是客户服务类占15.1%. What education can get in at Mayinglong? 本科占比最多占58.5%,其次是硕士占19.3%. High education required at Mayinglong? 硕士占19.3%,博士占2.8%. Work experience required at Mayinglong? 不限占比最多占34%,其次是3-5年占27.8%. Where are the job locations at Mayinglong? 武汉占比最多占63.7%,其次是深圳占8%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 43,105.3891万(元)
Legal Representative: 陈平
Date Established:
Credit Code: 91420100177701670K
Registered Address: 湖北省武汉市武昌南湖周家湾100号

Partners & Suppliers

国药股份采购马应龙的痔疮膏、栓剂等产品用于分销 Source
合作客户 中成药
战略合作连锁药店,直供合作伙伴 Source
合作客户 零售药店
战略合作连锁药店,直供合作伙伴 Source
合作客户 零售药店
战略合作连锁药店,直供合作伙伴 Source
合作客户 零售药店
战略合作连锁药店,直供合作伙伴 Source
合作客户 零售药店

People who follow Mayinglong also follow

Mayinglong Competitors (Similar Companies)

“Leading enterprise in Hubei pharmaceutical industry, one of China's to”
动力电池 充电电池 电池 储能电池
制药/药业 医药 功能食品 牛磺酸
“Promote the national optical communication industry”
“Let everyone in the world enjoy a better life through technology”
“Top Ten Enterprises in China's Beverage Industry”
“A technology-driven international pharmaceutical enterprise”
“Supplier of optical fibre preforms, optical fibres, and optical cables”
果汁 饮品 饮料 快速消费品
“Dietary lipid nutrients and solutions”
“Mainly engaged in the research, development and production of active p”
“Philosophy: We make the city we live in together a better place.”
“A large private modern pharmaceutical distribution enterprise in China”
抗生素 中成药 医药流通 医药商业
“全国领先的外用药生产制造商”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates